A phase II randomized study to evaluate a new psychosocial intervention (PI) plus early palliative care (PC) in the reduction of depression of advanced cancer patients (ACP): The PREPArE trial.

被引：0
|
作者：
Paiva, Carlos Eduardo
do Carmo, Thamires Monteiro
de Oliveira, Cleyton Zanardo
Nascimento, Maria Salete de Angelis
de Siqueira, Milena Ruas
Borges, Marielle
Paiva, Bianca Sakamoto Ribeiro
机构：
[1] Barretos Canc Hosp, Barretos, Brazil
[2] Fundacao Pio XII, Barretos, Brazil
[3] Barretos Canc Hosp, Dept Palliat Care, Barretos, Brazil
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.e21626
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21626
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A cluster randomized controlled trial comparing Virtual Learning Collaborative and Technical Assistance strategies to implement an early palliative care program for patients with advanced cancer and their caregivers: a study protocol
    Lisa Zubkoff
    Kathleen Doyle Lyons
    J. Nicholas Dionne-Odom
    Gregory Hagley
    Maria Pisu
    Andres Azuero
    Marie Flannery
    Richard Taylor
    Elizabeth Carpenter-Song
    Supriya Mohile
    Marie Anne Bakitas
    Implementation Science, 16
  • [32] The Project ENABLE Cornerstone randomized controlled trial: study protocol for a lay navigator-led, early palliative care coaching intervention for African American and rural-dwelling advanced cancer family caregivers
    Avery C. Bechthold
    Andres Azuero
    Maria Pisu
    Jennifer Young Pierce
    Grant R. Williams
    Richard A. Taylor
    Rachel Wells
    Kayleigh Curry
    Rhiannon D. Reed
    Erin R. Harrell
    Shena Gazaway
    Sarah Mollman
    Sally Engler
    Frank Puga
    Marie A. Bakitas
    J. Nicholas Dionne-Odom
    Trials, 23
  • [33] The Project ENABLE Cornerstone randomized controlled trial: study protocol for a lay navigator-led, early palliative care coaching intervention for African American and rural-dwelling advanced cancer family caregivers
    Bechthold, Avery C.
    Azuero, Andres
    Pisu, Maria
    Pierce, Jennifer Young
    Williams, Grant R.
    Taylor, Richard A.
    Wells, Rachel
    Curry, Kayleigh
    Reed, Rhiannon D.
    Harrell, Erin R.
    Gazaway, Shena
    Mollman, Sarah
    Engler, Sally
    Puga, Frank
    Bakitas, Marie A.
    Dionne-Odom, J. Nicholas
    TRIALS, 2022, 23 (01)
  • [34] A phase 2 quasi-experimental trial evaluating the feasibility, acceptability, and potential effectiveness of complex nursing intervention focused on QoL assessment on advanced cancer patients with palliative care needs: Study protocol
    Catania G.
    Bagnasco A.
    Signori A.
    Pilastri P.
    Bottino M.
    Cervetti C.
    Zanini M.
    Aleo G.
    Sasso L.
    Pilot and Feasibility Studies, 3 (1)
  • [35] A prospective, randomized, double-blinded, placebo controlled, phase III study to evaluate the efficacy and safety of apatinib plus best supportive care (BSC) compared to placebo plus BSC in patients with advanced or metastatic gastric cancer: The ANGEL study.
    Kang, Yoon-Koo
    Boku, Narikazu
    Kang, Won Ki
    Yoon, Harry H.
    Cascinu, Stefano
    Al-Batran, Salah-Eddin
    Houston, Scott
    Park, Cheol Hee
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [36] Phase II randomized trial of autologous tumor lysate dendritic cell vaccine (ADC) plus best supportive care (BSC) compared with BSC, in pre-treated advanced colorectal cancer patients.
    Maurel, Joan
    Caballero-Baos, Miguel
    Mila, Jordi
    Tabera, Jaime
    Varea, Sara
    Vilana, Ramon
    Bianchi, Luis
    Arguis, Pedro
    Pineda, Estela
    Carrera, Gemma
    Cuatrecasas, Miriam
    Paez, David
    Martin-Richard, Marta
    Pages, Mario
    Ramon Ayuso, Juan
    Cid, Joan
    Lozano, Miguel
    Garcia-Albeniz, Xabier
    Castells, Antoni
    Vilella, Ramon
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] A Phase I Trial of Cisplatin Plus Decitabine, a New DNA-Hypomethylating Agent, in Patients with Advanced Solid Tumors and a Follow-Up Early Phase II Evaluation in Patients with Inoperable Non-Small Cell Lung Cancer
    G. Schwartsmann
    H. Schunemann
    C.N.F. Gorini
    A.F. Ferreira Filho
    C. Garbino
    G. Sabini
    I. Muse
    L DiLeone
    D.R. Mans
    Investigational New Drugs, 2000, 18 : 83 - 91
  • [38] A phase I trial of cisplatin plus decitabine, a new DNA-hypomethylating agent, in patients with advanced solid tumors and a follow-up early phase II evaluation in patients with inoperable non-small cell lung cancer
    Schwartsmann, G
    Schunemann, H
    Gorini, CNF
    Ferreira, AF
    Garbino, C
    Sabini, G
    Muse, I
    DiLeone, L
    Mans, DR
    INVESTIGATIONAL NEW DRUGS, 2000, 18 (01) : 83 - 91
  • [39] Activity and toxicity of gemcitabine and gemcitabine plus vinorelbine in advanced non-small-cell lung cancer elderly patients -: Phase II data from the Multicenter Italian Lung Cancer in the Elderly Study (MILES) randomized trial
    Gridelli, C
    Cigolari, S
    Gallo, C
    Manzione, L
    Ianniello, GP
    Frontini, L
    Ferraù, F
    Robbiati, SF
    Adamo, V
    Gasparini, G
    Novello, S
    Perrone, F
    LUNG CANCER, 2001, 31 (2-3) : 277 - 284
  • [40] CCTG CO.26 trial: A phase II randomized study of durvalumab (D) plus tremelimumab (T) and best supportive care (BSC) versus BSC alone in patients (pts) with advanced refractory colorectal carcinoma (rCRC).
    Chen, Eric Xueyu
    Jonker, Derek J.
    Kennecke, Hagen F.
    Berry, Scott R.
    Couture, Felix
    Ahmad, Chaudhary E.
    Goffin, John R.
    Kavan, Petr
    Harb, Mohammed
    Colwell, Bruce
    Samimi, Setareh
    Samson, Benoit
    Abbas, Tahir
    Aucoin, Nathalie
    Aubin, Francine
    Koski, Sheryl L.
    Wei, Alice Chia-chi
    Magoski, Nadine M.
    Tu, Dongsheng
    O'Callaghan, Christopher J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
12345